Publications
Detailed Information
First-trimester screening for Down syndrome; the role of nasal bone assessment in the Korean population
Cited 5 time in
Web of Science
Cited 6 time in Scopus
- Authors
- Issue Date
- 2007-06-29
- Publisher
- Wiley
- Citation
- Prenat Diagn ;27: 830-834
- Keywords
- Down Syndrome/*diagnosis ; Female ; Humans ; Korea ; Nasal Bone/*anatomy & histology/embryology/ultrasonography ; Pregnancy ; Prospective Studies ; Ultrasonography, Prenatal ; Pregnancy Trimester, First
- Abstract
- OBJECTIVES: The aim of this study was to evaluate the role of nasal bone assessment in first-trimester screening for Down syndrome (DS) in the Korean population. METHODS: From July 2004 to March 2006, we prospectively evaluated the fetal nasal bones at 11-14 weeks' gestation in the Korean population. RESULTS: A successful evaluation was possible in 6490 of 6787 fetuses (95.6%). Absent, hypoechoic, and short nasal bones were seen in 4 (26.7%), 4 (26.7%), and 1 (6.7%) of 15 fetuses with DS, respectively, whereas in 5 (0.1%), 11 (0.2%), and 246 (3.8%) of 6456 normal fetuses. The incidence of absent and hypoechoic nasal bone showed significant differences between normal fetuses and fetuses with DS (P < 0.0005, both). Screening for DS using an absent or hypoechoic nasal bone resulted in a sensitivity of 53.3%, a specificity of 99.8%, a positive likelihood ratio of 215.2, and a negative likelihood ratio of 0.5. CONCLUSION: Our study showed that nasal bone abnormality at 11-14 weeks of gestation had a high association with DS in the Korean population. This suggests that nasal bone assessment can be used to supplement the current first-trimester screening for DS in the Korean population.
- ISSN
- 0197-3851 (Print)
- Language
- English
- URI
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17605156
https://hdl.handle.net/10371/10419
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.